The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women
- Conditions
- Hypertension in Pregnancy
- Interventions
- Drug: Anti-HypertensiveRadiation: UltrasoundRadiation: Doppler ultrasoundDiagnostic Test: complete blood countDiagnostic Test: Body mass index
- Registration Number
- NCT05673135
- Lead Sponsor
- Assiut University
- Brief Summary
Hypertensive disorders of pregnancy, include pre-existing and gestational hypertension, preeclampsia, and eclampsia, it complicates up to 10% of pregnancies and represents a significant cause of maternal and perinatal morbidity and mortality. Following the "National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy" recommendation is currently a systolic blood pressure (SBP) ⩾ of 140 mmHg and diastolic blood pressure (DBP) ⩾ of 90 mmHg. The diagnosis generally requires two separate measurements. Accepted across international guidelines are the following four categories: Chronic/pre-existing hypertension (Hypertension discovered preconception or prior to 20 weeks gestation), Gestational hypertension (Hypertension that appears de novo after 20 weeks gestation and normalizes after pregnancy), Preeclampsia-eclampsia (De novo hypertension after 20 weeks' gestation accompanied by proteinuria, other features of maternal organ dysfunction or uteroplacental dysfunction), Chronic/pre-existing hypertension with superimposed preeclampsia-eclampsia. Over the past 2 decades, extensive epidemiologic studies have clearly established that obesity is a major risk for gestational hypertension and preeclampsia. The risk of preeclampsia typically doubles with each 5-7 kg/m2 increase in pre-pregnancy. The mechanisms have only been partially explored; increased cytokine-mediated inflammation and oxidative stress, increased shear stress, dyslipidemia, and increased sympathetic activity1 have all been proposed as possible pathways. Few studies have examined the relationship between pre-pregnancy BMI, gestational weight gain (GWG), and the risk of preeclampsia. So, our study aims to evaluate the adverse maternal and fetal outcomes related to hypertension in obese and non-obese pregnant women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 260
- Women aged from 20-35 years.
- Pregnant women from 28-30 weeks.
- Pregnant women with a singleton pregnancy.
- Women with chronic or gestational hypertension.
- Women with normal baseline investigations (uncomplicated hypertension).
- Obese women and non-obese women.
- Women with preeclampsia/eclampsia.
- Women need urgent termination of pregnancy.
- Women with co-morbidities such as diabetes, renal diseases, cardiac ...etc.
- Women with confirmed fetal malformation.
- Women who will refuse to participate.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Obese hypertensive pregnant women Ultrasound - Obese hypertensive pregnant women Doppler ultrasound - Non-obese hypertensive pregnant women Anti-Hypertensive - Obese hypertensive pregnant women Anti-Hypertensive - Obese hypertensive pregnant women complete blood count - Non-obese hypertensive pregnant women Ultrasound - Non-obese hypertensive pregnant women Doppler ultrasound - Non-obese hypertensive pregnant women complete blood count - Obese hypertensive pregnant women Body mass index - Non-obese hypertensive pregnant women Body mass index -
- Primary Outcome Measures
Name Time Method The rate of adverse maternal outcome related to hypertension in both groups 3 month
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Women Health Hospital - Assiut university
🇪🇬Assiut, Egypt